Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does APIXABAN Cause Contraindicated product administered? 515 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 515 reports of Contraindicated product administered have been filed in association with APIXABAN (ELIQUIS). This represents 0.3% of all adverse event reports for APIXABAN.

515
Reports of Contraindicated product administered with APIXABAN
0.3%
of all APIXABAN reports
73
Deaths
236
Hospitalizations

How Dangerous Is Contraindicated product administered From APIXABAN?

Of the 515 reports, 73 (14.2%) resulted in death, 236 (45.8%) required hospitalization, and 61 (11.8%) were considered life-threatening.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 515 reports have been filed with the FAERS database.

What Other Side Effects Does APIXABAN Cause?

Death (18,501) Cerebrovascular accident (7,237) Atrial fibrillation (5,690) Off label use (5,590) Thrombosis (5,298) Fall (5,063) Cardiac disorder (4,917) Haemorrhage (4,770) Dyspnoea (4,379) Gastrointestinal haemorrhage (4,030)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which APIXABAN Alternatives Have Lower Contraindicated product administered Risk?

APIXABAN vs APOMORPHINE APIXABAN vs APRACLONIDINE APIXABAN vs APREMILAST APIXABAN vs APREPITANT APIXABAN vs APROTININ

Related Pages

APIXABAN Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered APIXABAN Demographics